Medical News Today: Clinical trial secrecy: ‘there are worse offenders than pharma’ - news from 2015-03-15


"The drug industry is the main target for public disclosure at The website was set up amid concerns that pharma sponsors and investigators running the trials “were selectively publishing trials that favored sponsors’ interests,” according to the lead author of a new study reviewing the registry. And pharma has failed, in the first 5 years of the registry examined by the research, to get data onto it within the required 12 months – just 17% of industry-sponsored trials covered by the law made it to the database within that time. But the review, from Dr. Monique Anderson, a cardiologist and researcher at the Duke Clinical Research Institute, and co-authors, finds there have been even worse levels of transparency against this measure ..."


From feeds:

Open Access Tracking Project (OATP) »

Tags: oa.comment oa.reports oa.medicine oa.biomedicine oa.clinical_trials oa.pharma

Date tagged:

03/15/2015, 09:03

Date published:

03/15/2015, 05:03